AMAG Pharmaceuticals Inc logo

AMAG - AMAG Pharmaceuticals Inc Share Price

$13.75 0.0  0.0%

Last Trade - 13/11/20

Sector
Healthcare
Size
Small Cap
Market Cap £348.9m
Enterprise Value £436.9m
Revenue £205.4m
Position in Universe th / 6630
Bullish
Bearish
Unlock AMAG Revenue
Momentum
Relative Strength (%)
1m -1.75%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
124.4 418.3 432.5 495.8 474 327.8 246.5 248.7 +21.4%
-73.1 -76.1 +352.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, AMAGPharmaceuticals, Inc. revenues decreased 11% to $210.6M.Net loss decreased 88% to $31.5M. Revenues reflect Ferahemesegment decrease of 40% to $76.4M, Makena segment decreaseof 50% to $48.2M. Lower net loss reflects Other Selling,general and Admin decrease of 42% to $120.5M (expense),Impairment of intangible assets decrease from $77.4M(expense) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AMAG Revenue Unlock AMAG Revenue

Net Income

AMAG Net Income Unlock AMAG Revenue

Normalised EPS

AMAG Normalised EPS Unlock AMAG Revenue

PE Ratio Range

AMAG PE Ratio Range Unlock AMAG Revenue

Dividend Yield Range

AMAG Dividend Yield Range Unlock AMAG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AMAG EPS Forecasts Unlock AMAG Revenue
Profile Summary

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated November 9, 1981
Public Since June 11, 1986
No. of Shareholders: 8,000
No. of Employees: 440
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange NASDAQ Global Select Market
Shares in Issue 34,725,063
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AMAG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AMAG
Upcoming Events for AMAG
Frequently Asked Questions for AMAG Pharmaceuticals Inc
What is the AMAG Pharmaceuticals Inc share price?

As of 13/11/20, shares in AMAG Pharmaceuticals Inc are trading at $13.75, giving the company a market capitalisation of £348.9m. This share price information is delayed by 15 minutes.

How has the AMAG Pharmaceuticals Inc share price performed this year?

Shares in AMAG Pharmaceuticals Inc are currently trading at $13.75 and the price has moved by 39.45% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AMAG Pharmaceuticals Inc price has moved by 19.27% over the past year.

What are the analyst and broker recommendations for AMAG Pharmaceuticals Inc?

Of the analysts with advisory recommendations for AMAG Pharmaceuticals Inc, there are there are currently 0 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for AMAG Pharmaceuticals Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will AMAG Pharmaceuticals Inc next release its financial results?

AMAG Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the AMAG Pharmaceuticals Inc dividend yield?

AMAG Pharmaceuticals Inc does not currently pay a dividend.

Does AMAG Pharmaceuticals Inc pay a dividend?

AMAG Pharmaceuticals Inc does not currently pay a dividend.

When does AMAG Pharmaceuticals Inc next pay dividends?

AMAG Pharmaceuticals Inc does not currently pay a dividend.

How do I buy AMAG Pharmaceuticals Inc shares?

To buy shares in AMAG Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AMAG Pharmaceuticals Inc?

Shares in AMAG Pharmaceuticals Inc are currently trading at $13.75, giving the company a market capitalisation of £348.9m.

Where are AMAG Pharmaceuticals Inc shares listed? Where are AMAG Pharmaceuticals Inc shares listed?

Here are the trading details for AMAG Pharmaceuticals Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AMAG
What kind of share is AMAG Pharmaceuticals Inc?

We were not able to load our ranking data for AMAG Pharmaceuticals Inc

Is there a AMAG Pharmaceuticals Inc share price forecast 2021?

Shares in AMAG Pharmaceuticals Inc are currently priced at $13.75. At that level they are trading at 13.02% premium to the analyst consensus target price of 0.00.

Analysts covering AMAG Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.63 for the next financial year.

How can I tell whether the AMAG Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AMAG Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 68.51%. At the current price of $13.75, shares in AMAG Pharmaceuticals Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AMAG Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for AMAG Pharmaceuticals Inc.

Who are the key directors of AMAG Pharmaceuticals Inc?

We were unable to find the directors for AMAG Pharmaceuticals Inc.

Who are the major shareholders of AMAG Pharmaceuticals Inc?

Here are the top five shareholders of AMAG Pharmaceuticals Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 14.08% (4.89m shares)
Caligan Partners, LP Hedge Fund
Percentage owned: 10.08% (3.50m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.88% (3.08m shares)
Palo Alto Investors LP Hedge Fund
Percentage owned: 8.52% (2.96m shares)
Magnetar Capital Partners LP Investment Advisor/Hedge Fund
Percentage owned: 6.85% (2.38m shares)
Similar to AMAG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.